GZMA 抗体
Quick Overview for GZMA 抗体 (ABIN6963890)
抗原
See all GZMA 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Native and recombinant Granzyme A
-
纯化方法
- Purified from in vitro cultures by protein G affinity chromatography.
-
过滤
- 0.2 μm filtered
-
免疫原
- Human granzyme A
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.5 mg/mL
-
缓冲液
- supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
-
有效期
- 18 months
-
-
-
: "CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma." in: International immunopharmacology, Vol. 50, pp. 146-151, (2018) (PubMed).
: "Exposure to particulate matter 2.5 (PM2.5) induced macrophage-dependent inflammation, characterized by increased Th1/Th17 cytokine secretion and cytotoxicity." in: International immunopharmacology, Vol. 50, pp. 139-145, (2018) (PubMed).
: "Interleukin 10 enhanced CD8+ T cell activity and reduced CD8+ T cell apoptosis in patients with diffuse large B cell lymphoma." in: Experimental cell research, Vol. 360, Issue 2, pp. 146-152, (2017) (PubMed).
: "Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma." in: Experimental hematology, Vol. 41, Issue 3, pp. 231-40, (2013) (PubMed).
-
: "CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma." in: International immunopharmacology, Vol. 50, pp. 146-151, (2018) (PubMed).
-
- GZMA (Granzyme A (Granzyme 1, Cytotoxic T-Lymphocyte-Associated serine Esterase 3) (GZMA))
-
别名
- Granzyme A
-
基因ID
- 3001
-
途径
- Apoptosis
抗原
-